Peng S, Wang H, Wang Z, Wang Q
Molecules. 2022; 27(21).
PMID: 36364196
PMC: 9654062.
DOI: 10.3390/molecules27217370.
Kling E, Spaller T, Schiefner J, Bonisch D, Winckler T
Nucleic Acids Res. 2018; 46(14):7250-7260.
PMID: 29945249
PMC: 6101501.
DOI: 10.1093/nar/gky582.
Li G, De Clercq E
Microbiol Mol Biol Rev. 2016; 80(3):679-731.
PMID: 27357278
PMC: 4981665.
DOI: 10.1128/MMBR.00065-15.
Hetti Arachchilage M, Piontkivska H
Virus Evol. 2016; 2(1).
PMID: 27152230
PMC: 4854294.
DOI: 10.1093/ve/vew002.
Tekeste S, Wilkinson T, Weiner E, Xu X, Miller J, Le Grice S
J Virol. 2015; 89(23):12058-69.
PMID: 26401032
PMC: 4645309.
DOI: 10.1128/JVI.01471-15.
Inhibiting the HIV integration process: past, present, and the future.
Di Santo R
J Med Chem. 2013; 57(3):539-66.
PMID: 24025027
PMC: 3926363.
DOI: 10.1021/jm400674a.
The N-end rule and retroviral infection: no effect on integrase.
Boso G, Tasaki T, Kwon Y, Somia N
Virol J. 2013; 10:233.
PMID: 23849394
PMC: 3716682.
DOI: 10.1186/1743-422X-10-233.
A protein ballet around the viral genome orchestrated by HIV-1 reverse transcriptase leads to an architectural switch: from nucleocapsid-condensed RNA to Vpr-bridged DNA.
Lyonnais S, Gorelick R, Heniche-Boukhalfa F, Bouaziz S, Parissi V, Mouscadet J
Virus Res. 2012; 171(2):287-303.
PMID: 23017337
PMC: 3552025.
DOI: 10.1016/j.virusres.2012.09.008.
Reverse Transcriptase and Cellular Factors: Regulators of HIV-1 Reverse Transcription.
Warren K, Warrilow D, Meredith L, Harrich D
Viruses. 2011; 1(3):873-94.
PMID: 21994574
PMC: 3185528.
DOI: 10.3390/v1030873.
Impairment of human immunodeficiency virus type-1 integrase SUMOylation correlates with an early replication defect.
Zamborlini A, Coiffic A, Beauclair G, Delelis O, Paris J, Koh Y
J Biol Chem. 2011; 286(23):21013-22.
PMID: 21454548
PMC: 3121452.
DOI: 10.1074/jbc.M110.189274.
Sequential deletion of the integrase (Gag-Pol) carboxyl terminus reveals distinct phenotypic classes of defective HIV-1.
Mohammed K, Topper M, Muesing M
J Virol. 2011; 85(10):4654-66.
PMID: 21367893
PMC: 3126176.
DOI: 10.1128/JVI.02374-10.
Peptidic HIV integrase inhibitors derived from HIV gene products: structure-activity relationship studies.
Suzuki S, Maddali K, Hashimoto C, Urano E, Ohashi N, Tanaka T
Bioorg Med Chem. 2010; 18(18):6771-5.
PMID: 20708407
PMC: 4486254.
DOI: 10.1016/j.bmc.2010.07.050.
Peptide HIV-1 integrase inhibitors from HIV-1 gene products.
Suzuki S, Urano E, Hashimoto C, Tsutsumi H, Nakahara T, Tanaka T
J Med Chem. 2010; 53(14):5356-60.
PMID: 20586421
PMC: 4486249.
DOI: 10.1021/jm1003528.
Analysis of the viral elements required in the nuclear import of HIV-1 DNA.
Riviere L, Darlix J, Cimarelli A
J Virol. 2009; 84(2):729-39.
PMID: 19889772
PMC: 2798343.
DOI: 10.1128/JVI.01952-09.
Functional analysis of N-terminal residues of ty1 integrase.
Moore S, Garfinkel D
J Virol. 2009; 83(18):9502-11.
PMID: 19570857
PMC: 2738233.
DOI: 10.1128/JVI.00159-09.
Identifying and characterizing a functional HIV-1 reverse transcriptase-binding site on integrase.
Wilkinson T, Januszyk K, Phillips M, Tekeste S, Zhang M, Miller J
J Biol Chem. 2009; 284(12):7931-9.
PMID: 19150986
PMC: 2658086.
DOI: 10.1074/jbc.M806241200.
von Hippel Lindau binding protein 1-mediated degradation of integrase affects HIV-1 gene expression at a postintegration step.
Mousnier A, Kubat N, Massias-Simon A, Segeral E, Rain J, Benarous R
Proc Natl Acad Sci U S A. 2007; 104(34):13615-20.
PMID: 17698809
PMC: 1959430.
DOI: 10.1073/pnas.0705162104.
Molecular mechanisms by which human immunodeficiency virus type 1 integrase stimulates the early steps of reverse transcription.
Dobard C, Briones M, Chow S
J Virol. 2007; 81(18):10037-46.
PMID: 17626089
PMC: 2045400.
DOI: 10.1128/JVI.00519-07.
Incorporation of human immunodeficiency virus type 1 reverse transcriptase into virus-like particles.
Liao W, Huang K, Chang Y, Wang S, Tseng Y, Chiang C
J Virol. 2007; 81(10):5155-65.
PMID: 17344306
PMC: 1900205.
DOI: 10.1128/JVI.01796-06.
Characterization of HIV-1 integrase N-terminal mutant viruses.
Lloyd A, Ng Y, Muesing M, Simon V, Mulder L
Virology. 2006; 360(1):129-35.
PMID: 17109911
PMC: 2094525.
DOI: 10.1016/j.virol.2006.10.007.